Clinical Trial Update: Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for HLX04-O in subjects with age-related macular degeneration across Phase 1 and Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• HLX04-O

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Age Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED